Status:
COMPLETED
Taurolidine Lock Solution in the Prevention of Catheter Related Bacteremia
Lead Sponsor:
Aarhus University Hospital
Collaborating Sponsors:
Danish Child Cancer Foundation
TauroPharm
Conditions:
Bacteremia
Neoplasms
Eligibility:
All Genders
Up to 17 years
Phase:
PHASE3
Brief Summary
Children with cancer need a long term tunnelled central venous catheter (TCVC) for the entire duration of their treatment. TCVCs are locked with heparin when not in use. The most frequent complication...
Detailed Description
The most frequent complications of long term TCVC are catheter related blood steam infections(CRBSI)often caused by microorganisms located in the biofilm formed on the inner surface of the TCVC after ...
Eligibility Criteria
Inclusion
- Children aged 0-17 years with malignant disease requiring a tunneled central venous catheter.
Exclusion
- No written consent from child or parents
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT00735813
Start Date
April 1 2008
End Date
September 1 2012
Last Update
September 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Department of Oncology A4, Aarhus Universityhospital, Skejby
Århus N, Denmark, 8200